Kailera Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-03-31 |
|---|---|---|
Revenue | $0 | $0 |
EBITDA | -84,559 | |
EBIT | -84,660 | |
Net Income | -78,865 | -17,983 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -68,310 | -18,201 |
Cash | 111,826 | |
Basic Shares | 117,948 |
Annual Financials
| Values in thousands | 2025-12-31 |
|---|---|
Revenue | $0 |
EBITDA | -158,030 |
EBIT | -158,340 |
Net Income | -148,955 |
Net Change In Cash | 0 |
Free Cash Flow | -122,298 |
Cash | 160,267 |
Basic Shares | 117,948 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$3.65 |